Sonio, co-founded by Deepak Prakash,
is a leading ultrasound AI software company based in Paris
Bengaluru, 03 September
2024: Samsung Medison, a global medical
equipment company and an affiliate of Samsung Electronics,
completed on August 31 the acquisition of Sonio SAS, a leading French
ultrasound AI software company. Sonio was co-founded by Indian startup
entrepreneur Deepak Prakash, who also is the company’s CTO.
The
closing of the transaction was subject to applicable regulatory approvals,
notably the approval of the French Ministry
of the Economy and Finance.
Following the completion of the transaction,
Sonio will remain an independent company headquartered in France and will
continue its commercial growth independently.
Sonio
was established in 2020 with a mission to enhance women and children’s health
globally. The company developed industry leading IT solutions and AI assistant
features for obstetrics and gynaecology ultrasound that robustly assisted
medical professionals in the evaluation and documentation of ultrasound exams.
Sonio
Detect, an FDA 510(k) cleared AI assistant, provides accurate feedback on
ultrasound examination quality and demonstrates remarkable performance with
over 90% sensitivity in recognizing fetal ultrasound views. Together with
Sonio’s world-class AI expertise, Samsung Medison’s leading-edge ultrasound
systems will help bring to market, breakthrough AI- enhanced workflows and
accelerate innovation in patient outcomes and quality of prenatal care.
Deepak Prakash
had graduated in Computer Science
in 2006 from Model Engineering College (MEC), Ernakulam, Kerala. He then started working on
layout modeling for a chip design software (Apache Design) which was acquired
by Ansys. Later, he took the entrepreneurial route by founding Zoomdeck, a
web/mobile startup. In 2014, he moved to Paris to become one of the early
employees of an ad-tech startup AlephD which was then bought by AOL.
“The
opportunity to build something profoundly impactful at the intersection of
healthcare, AI and real time-tech is what drew me to Sonio,” said Deepak Prakash, CTO. Being passionate about startups and tech, he
enjoys taking a sustainable approach to problems. “Samsung's acquisition is a
testament to the impact we have created thanks to the incredible tech, products
and team we built in the past years. It is truly special that Indian engineers
figure prominently in our exceptional team,” he said. Together, Samsung
and Sonio aim to bring
about
a transformational shift in prenatal ultrasound examinations that would
especially be a gamechanger in developing regions of the world including
India,” Prakash added.
Said Yong Kwan Kim, Samsung Medison CEO, “We
have great respect and admiration for what the Sonio team has built in the area of maternal
care. Through the acquisition of Sonio,
Samsung Medison will continue to deliver upon our promise to improve the
quality of people’s lives with technology.” The collaboration with Sonio will bring together
best-in-class ultrasound AI technology and reporting capabilities, he
added.
“Samsung Medison’s
established global ultrasound business combined with Sonio’s advanced AI creates an exciting
growth opportunity for both sides,”
said Cécile Brosset, Sonio CEO and Co-founder. “In addition to close
collaboration with Samsung Medison, as an independent company, Sonio will
continue to advance medical reporting technology and diagnostic software
globally, including for underserved areas in healthcare.”
About Samsung Medison: Samsung Medison is a leading global medical device
company, specializing in diagnostic imaging devices. With a mission to bring
health and well-being to people’s lives, the company is committed to creating a
new future for medical professionals and patients around the world across
various medical fields. In 2011, Samsung Medison became an affiliate company of
Samsung Electronics, integrating the world’s best IT, image processing,
semiconductor and communication technologies into medical devices. For more
information, please visit https://www.samsungmedison.com/
About Sonio: Sonio’s AI-enhanced software empowers prenatal
sonographers and ultrasound readers and assists them in
performing prenatal examinations that meet the highest quality standards, while ensuring the completeness of each examination, streamlining their workflow and increasing the accuracy of
prenatal diagnoses. Sonio’s software is the product of more than five years of
research and collaboration between leading experts in the areas of
maternal-fetal medicine and AI. Sonio’s investors include Elaia Partners,
Bpifrance’s French Tech Seed fund, OneRagtime, Cross Border Impact Ventures and
EIC Fund (European Innovation Council). To learn more about Sonio, visit our
website https://sonio.ai/
Media Contacts:
Cocoa Tree Communications Pvt. Ltd
Manju Cimani
9986075756